A detailed history of Clifford Swan Investment Counsel LLC transactions in Abbott Laboratories stock. As of the latest transaction made, Clifford Swan Investment Counsel LLC holds 217,768 shares of ABT stock, worth $27.9 Million. This represents 0.89% of its overall portfolio holdings.

Number of Shares
217,768
Previous 221,516 1.69%
Holding current value
$27.9 Million
Previous $23 Million 7.86%
% of portfolio
0.89%
Previous 0.87%

Shares

30 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Nov 14, 2024

SELL
$100.07 - $118.13 $375,062 - $442,751
-3,748 Reduced 1.69%
217,768 $24.8 Million
Q2 2024

Aug 06, 2024

SELL
$100.73 - $112.44 $169,125 - $188,786
-1,679 Reduced 0.75%
221,516 $23 Million
Q1 2024

Apr 16, 2024

SELL
$109.52 - $120.96 $926,101 - $1.02 Million
-8,456 Reduced 3.65%
223,195 $25.4 Million
Q4 2023

Feb 06, 2024

SELL
$90.19 - $110.4 $72,061 - $88,209
-799 Reduced 0.34%
231,651 $25.5 Million
Q3 2023

Nov 09, 2023

SELL
$95.53 - $114.62 $242,932 - $291,478
-2,543 Reduced 1.08%
232,450 $22.5 Million
Q2 2023

Aug 03, 2023

SELL
$100.78 - $112.29 $164,372 - $183,144
-1,631 Reduced 0.69%
234,993 $25.6 Million
Q1 2023

May 05, 2023

SELL
$96.86 - $114.01 $334,845 - $394,132
-3,457 Reduced 1.44%
236,624 $24 Million
Q4 2022

Feb 02, 2023

SELL
$95.06 - $111.52 $90,972 - $106,724
-957 Reduced 0.4%
240,081 $26.4 Million
Q3 2022

Nov 04, 2022

SELL
$96.76 - $112.03 $1.29 Million - $1.5 Million
-13,357 Reduced 5.25%
241,038 $23.3 Million
Q2 2022

Aug 04, 2022

SELL
$102.07 - $123.37 $136,977 - $165,562
-1,342 Reduced 0.52%
254,395 $27.6 Million
Q1 2022

May 03, 2022

SELL
$114.02 - $139.04 $425,408 - $518,758
-3,731 Reduced 1.44%
255,737 $30.3 Million
Q4 2021

Feb 11, 2022

SELL
$115.53 - $141.46 $15,481 - $18,955
-134 Reduced 0.05%
259,468 $36.5 Million
Q3 2021

Nov 02, 2021

SELL
$116.66 - $129.06 $19,598 - $21,682
-168 Reduced 0.06%
259,602 $30.7 Million
Q2 2021

Aug 05, 2021

SELL
$105.79 - $124.53 $852,032 - $1 Million
-8,054 Reduced 3.01%
259,770 $31.6 Million
Q1 2021

May 07, 2021

SELL
$108.84 - $128.23 $206,904 - $243,765
-1,901 Reduced 0.7%
267,824 $32.1 Million
Q4 2020

Feb 11, 2021

SELL
$105.0 - $114.42 $233,835 - $254,813
-2,227 Reduced 0.82%
269,725 $29.5 Million
Q3 2020

Oct 30, 2020

SELL
$91.64 - $111.29 $183,463 - $222,802
-2,002 Reduced 0.73%
271,952 $29.6 Million
Q2 2020

Aug 06, 2020

SELL
$76.57 - $98.0 $243,645 - $311,836
-3,182 Reduced 1.15%
273,954 $25 Million
Q1 2020

Apr 09, 2020

SELL
$62.82 - $91.86 $212,143 - $310,211
-3,377 Reduced 1.2%
277,136 $21.9 Million
Q4 2019

Jan 30, 2020

SELL
$78.51 - $87.4 $192,663 - $214,479
-2,454 Reduced 0.87%
280,513 $24.4 Million
Q3 2019

Nov 12, 2019

SELL
$81.84 - $88.74 $51,886 - $56,261
-634 Reduced 0.22%
282,967 $23.7 Million
Q2 2019

Aug 13, 2019

SELL
$72.88 - $85.0 $603,227 - $703,545
-8,277 Reduced 2.84%
283,601 $23.9 Million
Q1 2019

May 14, 2019

SELL
$66.22 - $80.06 $1.49 Million - $1.8 Million
-22,483 Reduced 7.15%
291,878 $23.3 Million
Q4 2018

Feb 13, 2019

BUY
$65.56 - $74.27 $8,719 - $9,877
133 Added 0.04%
314,361 $22.7 Million
Q3 2018

Nov 14, 2018

SELL
$60.81 - $73.36 $189,848 - $229,029
-3,122 Reduced 0.98%
314,228 $23.1 Million
Q2 2018

Aug 13, 2018

SELL
$57.57 - $63.54 $283,417 - $312,807
-4,923 Reduced 1.53%
317,350 $19.4 Million
Q1 2018

May 09, 2018

SELL
$56.27 - $63.62 $681,429 - $770,438
-12,110 Reduced 3.62%
322,273 $19.3 Million
Q4 2017

Feb 09, 2018

BUY
$53.68 - $57.47 $582,642 - $623,779
10,854 Added 3.35%
334,383 $19.1 Million
Q3 2017

Nov 13, 2017

SELL
$48.06 - $53.64 $292,877 - $326,882
-6,094 Reduced 1.85%
323,529 $17.3 Million
Q2 2017

Aug 11, 2017

BUY
N/A
329,623
329,623 $16 Million

Others Institutions Holding ABT

About ABBOTT LABORATORIES


  • Ticker ABT
  • Exchange NYSE
  • Sector Healthcare
  • Industry Medical Devices
  • Shares Outstandng 1,751,219,968
  • Market Cap $224B
  • Description
  • Abbott Laboratories, together with its subsidiaries, discovers, develops, manufactures, and sells health care products worldwide. It operates in four segments: Established Pharmaceutical Products, Diagnostic Products, Nutritional Products, and Medical Devices. The Established Pharmaceutical Products segment provides generic pharmaceuticals for t...
More about ABT
Track This Portfolio

Track Clifford Swan Investment Counsel LLC Portfolio

Follow Clifford Swan Investment Counsel LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Clifford Swan Investment Counsel LLC, based on Form 13F filings with the SEC.

News

Stay updated on Clifford Swan Investment Counsel LLC with notifications on news.